对Mycobacterium结核病基因组序列的大规模统计分析确定了与多药耐药性相关的补偿突变
Nina Billows1,2, Jody Phelan3, Dong Xia4
1Royal Veterinary College, University of London, London, UK. Nina.Billows@LSHTM.ac.uk.
Scientific reports
|May 29, 2024
概括
一个新的框架,CompMut-TB,识别了Mycobacterium结核病菌株中的补偿突变. 这有助于了解耐药结核病的演变和分析治疗耐药性的情况.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 结核病 (TB) 构成了全球健康威胁,多种耐药菌株加剧了这一威胁.
- 对第一线药物异化和利芬素的耐药性与特定基因突变 (katG,rpoB) 和相关的健身成本有关.
- 补偿突变可以减轻这些健康成本,帮助耐药菌株的生存.
研究的目的:
- 开发一个计算框架 (CompMut-TB) 用于检测结核菌菌中的补偿突变.
- 分析大量的全基因组序列数据集,以确定新的补偿突变.
- 提高对驱动结核病耐药性的进化机制的理解.
主要方法:
- 分析了来自18396个Mycobacterium结核病样本的全基因组测序数据.
- 关联分析 (费舍尔精确测试) 确定了与药物耐药性相关的突变对.
- 调解分析确定了作为药物耐药性调解者的突变.
主要成果:
- 在CompMut-TB框架成功地发现了潜在的补偿突变.
- 在rpoC,rpoA和oxyR'-ahpC基因中发现了几种可能的补偿突变.
- 确定的突变包括先前验证的补偿变异.
结论:
- CompMut-TB提供了一种有价值的工具,用于识别耐药结核病的补偿突变.
- 这一框架支持精确的基于基因组的结核病菌株分析.
- 这些发现有助于更深入地了解结核病耐药性的演变.
相关概念视频
Mismatch Repair
Overview
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Mutations in Microorganisms
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...


